Foamix (FOMX) Enters Sale Agreement with Cantor Fitzgerald Covering up to $30M in Stock Aug 19, 2019 04:40PM
Cantor Fitzgerald Reiterates Overweight Rating on Foamix Pharmaceuticals (FOMX) Amid Finacea Foam Settlement Apr 2, 2019 12:01PM
Foamix (FOMX) R&D Day Offers 3 New Products - Cantor Jan 25, 2019 07:48AM
Pre-Open Movers 12/12: (FOMX) (BTAI) (CORT) Higher; (SGYP) (NBIX) (PLAY) Lower (more...) Dec 12, 2018 09:30AM
Pre-Open Movers 11/07: (TWLO) (ARRS) (GNC) Higher; (MDXG) (INFN) (INGN) Lower (more...) Nov 7, 2018 09:31AM


Oct 12, 2018 09:20AM Pre-Open Movers 10/12: (CORI) (TTPH) (SQ) Higher; (IMDZ) (TRVN) Lower (more...)
Oct 11, 2018 05:42PM After-Hours Stock Movers 10/11: (CORI) (TTPH) (PGNX) Higher; (TRVN) (IMDZ) Lower (more...)
Oct 11, 2018 04:05PM Cantor Fitzgerald Starts Foamix Pharmaceuticals (FOMX) at Overweight
Oct 1, 2018 08:05AM Foamix (FOMX) Announces Additional Positive Topline Results from Third Phase 3 Trial Evaluating FMX101
Oct 1, 2018 08:00AM Foamix Announces Additional Positive Topline Results from Third Phase 3 Trial (Study FX2017-22) Evaluating FMX101 Topical Minocycline Foam for Moderate-to-Severe Acne
Sep 26, 2018 08:00AM Foamix Pharmaceuticals to Participate in the Cantor Fitzgerald Global Healthcare Conference
Sep 18, 2018 10:55AM Foamix Announces Closing of its Follow-on Offering of Ordinary Shares and Full Exercise of its Option by the Underwriters
Sep 14, 2018 06:23AM Foamix (FOMX) Prices 11.67M Share Follow-On Offering at $6/Sh
Sep 13, 2018 07:06PM Foamix Announces Pricing of its Follow-on Offering of Ordinary Shares
Sep 12, 2018 04:33PM Foamix (FOMX) Announces Proposed Follow-On Share Offering
Sep 12, 2018 04:31PM Foamix Announces Proposed Follow-on Offering of Ordinary Shares